1 Market Overview and Growth Trajectory The global ​Triazolam market​ represents a significant segment within the pharmaceutical industry, specializing in the production and distribution of this short-acting benzodiazepine primarily prescribed for managing insomnia and anxiety disorders. According to comprehensive market research, the Triazolam market was valued at approximately ​USD 0.5 billion in 2022​ and is projected to reach ​USD 0.8 billion by 2030, growing at a compound annual growth rate (CAGR) of ​6.5% from 2024 to 2030​ . This substantial growth is driven by multiple factors including the increasing prevalence of sleep disorders worldwide, with approximately 30% of adults in the United States experiencing insomnia symptoms, and about 10% suffering…